| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 07/21/2005 | DE10359791A1 Substituierte Thiophene Substituted thiophenes |
| 07/21/2005 | CA2552946A1 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof |
| 07/21/2005 | CA2552850A1 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof |
| 07/21/2005 | CA2551346A1 N-substituted piperidine and piperazine derivatives |
| 07/21/2005 | CA2550189A1 Thiadiazoles as cxc- and cc- chemokine receptor ligands |
| 07/21/2005 | CA2549396A1 Cb1 modulator compounds |
| 07/21/2005 | CA2549330A1 Calcitonin gene related peptide receptor antagonists |
| 07/20/2005 | EP1555264A1 Five-membered heterocyclic compounds as inhibitors of SRC family protein kinase. |
| 07/20/2005 | EP1555021A1 Combinations of a mevalonate pathway inhibitor and a PPAR-gamma agonist for treating cancer |
| 07/20/2005 | EP1554275A2 Compounds |
| 07/20/2005 | EP1554274A1 1-acyl-pyrrolidine derivatives for the treatment of viral infections |
| 07/20/2005 | EP1554272A1 Benzimidazoles and benzothiazoles as inhibitors of map kinase |
| 07/20/2005 | EP1554271A1 Substituted indoles and their use as hcv inhibitors |
| 07/20/2005 | EP1554269A1 Imidazoles, oxazoles and thiazoles with protein kinase inhibiting activities |
| 07/20/2005 | EP1554260A1 Aryloxyalkylamine derivatives as h3 receptor ligands |
| 07/20/2005 | EP1554250A1 Novel lactams and uses thereof |
| 07/20/2005 | EP1554239A2 Sulfonylamino-acetic acid derivatives and their use as orexin receptor antagonists |
| 07/20/2005 | EP1553949A2 Pyrimidine-2,4-dione derivatives as matrix metalloproteinase inhibitors |
| 07/20/2005 | EP1553947A2 Quinazolinones and derivatives thereof as factor xa inhibitors |
| 07/20/2005 | EP1379511B1 DIHYDRO-BENZO (b) (1, 4) DIAZEPIN-2-ONE DERIVATIVES AS MGLUR2 ANTAGONISTS II |
| 07/20/2005 | EP1303514B1 Process for preparing azacycloalkanoylaminothiazoles |
| 07/20/2005 | EP1303512B1 Process for preparing arylacetylaminothiazoles |
| 07/20/2005 | EP1286673B8 Ligands of integrin receptors |
| 07/20/2005 | EP1272484B1 Benzoamide piperidine compounds as substance p antagonists |
| 07/20/2005 | EP1189583B1 Indole derivatives |
| 07/20/2005 | EP1175402B1 Piperidine derivatives useful as ccr5 antagonists |
| 07/20/2005 | CN1642951A Heterocyclic tripeptides as hepatitis c inhibitors |
| 07/20/2005 | CN1642939A Pyridinoylpiperidines as 5-HTLF agonists |
| 07/20/2005 | CN1642938A New compounds |
| 07/20/2005 | CN1642929A Kappa-opioid receptor agonist comprising 2-phenylbenzothiazoline derivative |
| 07/20/2005 | CN1642925A Novel tetrazole derivative useful as herbicides |
| 07/20/2005 | CN1642924A Anxiolytic agents with reduced sedative and ataxic effects |
| 07/20/2005 | CN1642917A Non-peptide GnRH antagonists |
| 07/20/2005 | CN1642915A Benzamide derivatives useful as histone deacetylase inhibitors |
| 07/20/2005 | CN1642910A Synthesis of indole thiazole compounds as ligands for the AH receptor |
| 07/20/2005 | CN1642600A 1, 2-dihydropyrazol-3-ones which controls inflammatory cytokines |
| 07/20/2005 | CN1642599A ACC inhibitors |
| 07/20/2005 | CN1642580A Radiolabelled quinoline and quinolinone derivatives and their use as metabotropic glutamate receptor ligands |
| 07/20/2005 | CN1642422A 4-aminopyrimidines and their use for the antimicrobial treatment of surfaces |
| 07/20/2005 | CN1211384C Thiadiazolyl and oxidiazolyl phenyl oxazolidinone antibacterial agent |
| 07/20/2005 | CN1211382C Quinazoline ditosylate salt compounds |
| 07/20/2005 | CN1211374C Heterocyclic derivative, its preparation method and medicine compositioncontaining them |
| 07/20/2005 | CN1211373C 2,d-di (hetero-) arylamino (-oxy)-5-substituted pyrimidines as antineoplastic agents |
| 07/20/2005 | CN1211367C Prostaglandin agonists and their use to treat bone disorders |
| 07/19/2005 | US6919482 A 1,4-bis(N-(2-(4-hydroxy-3-hydroxymethylphenyl) -2-hydroxyethyl)amino)-cyclohexane or alkyl-cyclohexane or -pyrazine derivatives; treating respiratory diseases disorders, asthma, bronchitis, nervous system injury |
| 07/19/2005 | US6919375 Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same |
| 07/19/2005 | US6919371 Antidiabetic agents; dietetics; gastrointestinal disorders |
| 07/19/2005 | US6919368 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 07/19/2005 | US6919367 Substituted thioacetamides |
| 07/19/2005 | US6919362 For use as hypoglycaemic and hypolipidaemic agents |
| 07/19/2005 | US6919361 Five-membered-ring compound |
| 07/19/2005 | US6919360 Benzisothiazolyl-substituted aminomethyl chromanes for treating diseases of the central nervous system |
| 07/19/2005 | US6919359 Azabicyclic-substituted-heteroaryl compounds for the treatment of disease |
| 07/19/2005 | US6919358 Substituted acid derivatives useful as antidiabetic and antiobesity agents and method |
| 07/19/2005 | US6919356 Antihistamines, antiallergens, autoimmune disease, antiinflammatory agents |
| 07/19/2005 | US6919355 Amide derivatives as NMDA receptor antagonists |
| 07/19/2005 | US6919353 Enzyme inhibitors of phosphordiesterase 4 having minimal side effects; antiinflammatory agents; antiallergens; asthma; neurodegenerative disorders; antidiabetic agents; pain; anti-tumor, -carcinogenic and -arthritic agents |
| 07/19/2005 | US6919347 Antidiabetic agents; antiinflammatory agents; analgesics; antiallergens |
| 07/19/2005 | US6919338 Antiproliferative agents; anticancer agents |
| 07/19/2005 | US6919335 Heterocycles that are inhibitors of IMPDH enzyme |
| 07/19/2005 | US6919329 Microorganisms; bactericides; human and veterinary medicine |
| 07/14/2005 | WO2005063743A1 Thiazole derivative |
| 07/14/2005 | WO2005063742A2 Amidino compounds as cysteine protease inhibitors |
| 07/14/2005 | WO2005063739A1 Novel quinoline derivatives |
| 07/14/2005 | WO2005063738A1 Novel 2-heteroaryl-substituted benzimidazole derivative |
| 07/14/2005 | WO2005063737A1 Amidopyrazole derivative |
| 07/14/2005 | WO2005063734A2 Substituted thiophenes |
| 07/14/2005 | WO2005063725A1 Phenylpropanoic acid derivatives |
| 07/14/2005 | WO2005063704A1 Azetidine ring compounds and drugs comprising the same |
| 07/14/2005 | WO2005063244A1 Acidic quinoline derivatives and their use for the prevention and/or treatment of hyperglycaemia-related pathologies |
| 07/14/2005 | WO2005051946A3 Compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity |
| 07/14/2005 | WO2005049579A3 Immobilized n-substituted tricyclic 3-aminopyrazoles for the identification of biomolecular targets |
| 07/14/2005 | WO2005037781A3 Derivatives of n-[heteroaryl(piperidine-2-yl)methyl]benzamide, preparation method thereof and application of same in therapeutics |
| 07/14/2005 | US20050154039 5-Sulphanyl-4h-1,2,4-triazole derivatives and their use as medicine |
| 07/14/2005 | US20050154038 bicyclo[2.2.2]-oct-1-yl-1,2,4-triazoles; type 2 diabetes, lipid disorders, obesity, atherosclerosis, metabolic syndrome, hyperglycemia, insulin resistance; increase insulin sensitivity in muscle, liver and adipose tissue by correction of the elevated plasma levels of glucose without causing hypoglycemia |
| 07/14/2005 | US20050154027 Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists |
| 07/14/2005 | US20050154023 1-(4-methoxynaphthalene-1-sulfonyl)-2,3-dihydro-1H-indole-3-carboxylic acid [2-(1-methyl-pyrrolidin-2-yl)-ethyl]amide; selective affinity for 5-HT6 receptor; psychosis, schizophrenia, depression, neurological disorders, cognitive enhancement, Parkinson's disease, ALS, Alzheimer's, Huntington's disease |
| 07/14/2005 | US20050154019 Substituted cyclic amine metalloprotease inhibitors |
| 07/14/2005 | US20050154012 Substituted 3-aryl-5-aryl-[1,2,4]-oxadiazoles and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 07/14/2005 | US20050153987 Compounds |
| 07/14/2005 | US20050153986 Psychiatric and mood disorders, Bipolar Disorder, Circadian rhythm disorders, sleep disorders, pain, Parkinson's disease, cognitive dysfunction, epilepsy, obesity, drug addiction, drug abuse, drug withdrawal; side effects reduction; 1-Methyl-3-[3-(5-pyridin-2-yl-2H-tetrazol-2-yl)phenyl]imidazolidin-2-one |
| 07/14/2005 | US20050153984 4-[5-(4-trifluoromethyl-phenyl)-pyridin-3-yloxy]-benzothiazol-2-ylamine; inflammatory or neuropathic pain and diseases involving sensory nerve function such as asthma, rheumatoid arthritis, osteoarthritis, inflammatory bowel disorders, urinary incontinence, migraine and psoriasis |
| 07/14/2005 | US20050153980 Substituted indoles |
| 07/14/2005 | US20050153979 Novel piperidine-substituted indoles-or heteroderivatives thereof |
| 07/14/2005 | US20050153977 N-[4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)thiazol-2-yl]-3-fluoro-4-hydroxybenzamide; nonpeptide c-mpl ligand; low immunogenicity; proliferate human c-mpl-Ba/F3 cells; increase platelets by promoting the formation of megakaryocytic colonies; orally |
| 07/14/2005 | US20050153964 Novel compounds |
| 07/14/2005 | US20050153962 2,4-dichloro-N-(4-chloro-3-methoxy-phenyl)-N-[4-(pyrrolidine-1-carbonyl)thiazole-2-yl]-benzamide; cannabionic receptor (CB1) antagonist and inverse agonists; side effects reduction; amidation of aminothiazol derivatives with acid chloride and coupling by dehydroxylation with alcohol or amine derivatives |
| 07/14/2005 | US20050153960 Substituted arylamine derivatives and methods of use |
| 07/14/2005 | US20050153951 Neurotrophic pyrrolidines and piperidines, and related compositions and methods |
| 07/14/2005 | US20050153944 Oxazole derivatives of tetracyclines |
| 07/14/2005 | US20050153942 Heterocyclic inhibitors of MEK and methods of use thereof |
| 07/14/2005 | US20050153900 Novel inhibitors of hepatitis C virus NS3/NS4a serine protease |
| 07/14/2005 | US20050153371 Conjugated small molecules |
| 07/14/2005 | CA2551611A1 Thiazole derivatives for treating or preventing parkinson's disease |
| 07/14/2005 | CA2551604A1 Amidopyrazole derivative |
| 07/14/2005 | CA2551227A1 Acidic quinoline derivatives and their use for the prevention and/or treatment of hyperglycaemia-related pathologies |
| 07/14/2005 | CA2550428A1 Substituted thiophenes |
| 07/13/2005 | EP1553179A1 Mouse-origin proteins forming domain or use thereof |
| 07/13/2005 | EP1553097A1 Quinazoline derivatives as angiogenesis inhibitors and intermediates therefore |
| 07/13/2005 | EP1553091A1 Heteroaromatic pentacyclic compound and medicinal use thereof |